Клинико-эндоскопическая и морфологическая характеристика состояния слизистой оболочки желудка при системной красной волчанке и антифосфолипидном синдроме
Диссертация
Больные СКВ с АФС, в отличие от пациентов СКВ без АФС, характеризовались большей инфильтрацией молодыми и зрелыми плазматическими клетками поверхностного и глубокого слоев СОЖ. Этот факт пока не нашел своего объяснения. Характерным также было наличие ассоциации между увеличением количества фиброцитов глубокого слоя СОЖ и развитием атрофии. Данный феномен объясняется известной ролью фиброцитов… Читать ещё >
Список литературы
- Автандилов Г. Г. Проблемы патогенеза и патологической диагностики болезней в аспекте морфометрии. М. Медицина, 1984.
- Аруин Л.Г., Григорьев ПЛ., Исаков В. А., Яковенко Э. П. Хронический гастрит. Амстердам, 1993. С. 162, 265−284.
- Аруин Л.Г., Капуллер JI.JI., Исаков В. А. Морфологическая диагностика болезней желудка и кишечника. М. Триада X. 1998. — С.73−75, 108−109, 117.
- Бокарев И.Н., Козлова Т. В. Принципы рациональной терапии оральными антикоагулянтами. // Тромбоз, гемостаз и реология. — 2000.-№ 4 (4). С.16−21.
- Виноградова М.А., Газизова P.P., Новикова А. В. и соавт. Особенности течения язвенной болезни при наличии хеликобактериоза и герпетической инфекции. // Клин. мед. 1997. — № 5. — С. 26−27.
- Глинских. Н.П. Неизвестная эпидемиология: герпес. Смоленск. — 1997. -С.32−57.
- Егорова О.Н., Балабанова P.M., Чувиров Г. Н. Значение антител к семейству Herpesviridae при ревматических заболеваниях. // Тер.арх.-1998. № 5. — С.70.
- Ивашкин В.Т. Патогенез гастропатий, обусловленных приемом нестороидных противовоспалительных препаратов. // Рос. журн. гастроэнтер., гепатол., колопроктол. 1994. — Т.4, № 1. — С. 11−14.
- Ивашкин В.Т., Мегро Ф., Лапина Т.Л. Helicobacter ру1оп: революция в гастроэнтерологии.М. Триада-Х. 1999.- С. 41−44.
- Каратеев А.Е., Насонова В. А., Муравьев Ю. В. Влияние ГКС и НПВП на слизистую ЖКТ у больных ревматическими заболеваниями. // Тер. арх. -1999. Т.79, № 2. — С.34−39.
- Каратеев А.Е., Муравьев Ю. В. Гастропатии в ревматологии у пациентов пожилого возраста индуцированного НПВП. // Клин, герантология.2000.-№ 7/8.-С. 13−16.
- Клиническая иммунология и аллергрлогия. под редакцией Иегера Л. М. Медицина. -т.З. С.214−216.
- Логинов А.С., Аруин Л. И., Ильченко А. А. Язвенная болезнь и Helicobacter pylori: новые аспекты патогенетической терапии. М Медицина. -1993. С. 54−55.
- Муравьев Ю.В., Алексеева А. В. Всегда ли терапия «безопасными» НПВП безопасна для слизистой оболочки желудочно-кишечного тракта? // Российский гастроэнтерологический журнал. 2000. — № 2.- - С.84−88.
- Мусаев С.Н. Состояние органов пищеварения при диффузных болезных соединительной ткани (Системная красная волчанка, Системная склеродермия, Дерматомиозит) у детей. Автореф. дисс. докт. мед. наук. Москва, 1991.
- Насонова В.А. Системная красная волчанка. М. Медицина, 1972.- С.84−85.
- Насонов Е.Л. Антифосфолшщдный синдром: клиническая и иммунологическая характеристика. // Клин. мед. 1989. — № 1. — С. 5−13.
- Насонов Е.Л., Баранов А. А., Шилкина Н. П. Васкулиты и васкулопатии.// Ярославль. Верхняя Волга.- 1999. С. 540−541, 557−558.
- Насонов Е.Л., Каратеев А. Е. Гастропатии связанные с приемом нестероидных противовоспалительных препаратов. // Клин. мед. 2000 -№ 4. — С.4−9.
- Насонов E.JI., Цветкова Е. С., Тов Н.Д. Селективные ингибиторы циклооксигеназы-2: новые перспективы лечения заболеваний человека. // Тер. арх. 1998. — № 5. — С.8−14.
- Новикова А.В., Сичинава И. В., Шершевская АЛ. и др. Течение хронического хеликобактерного гастрита у детей и подростков. // Материалы 8-й тематической сессии Российской группы по изучению Helicobacter pylori. Уфа 1999. — С.51−55.
- Павлюк А.С. Методы лабораторной диагностики заболеваний, вызванных вирусом простого герпеса. // 3 111 111. 1994. — № 3. — С. 3−7.
- Раденска-Лоповок С.Г., Решетняк Т. М. Патология сосудов 2002.- № 1 -С. 50−54:
- Раденска-Лоповок С.Г., Решетняк Т. М., Забек Я., Вайцеховска Б. Морфологические особенности сосудов при антифосфолипидном синдроме. // Арх. патол. 2001. — № 6- С.8−11.
- Решетняк Т.М. Антифосфолипидный синдром: диагноз и принципы терапии. II Consilium medicum. 2002. — № 4 (8). С.408−414.
- Решетняк Т.М., Алекберова З. С., Насонов Е. Л., Насонова В. А. Принципы лечения антифосфолипидного синдрома при системной красной волчанке. // Тер. арх.- 1998. № 5. — С.83−86.
- Решетняк Т.М., Алекберова З. С. Антифосфолипидный синдром: серологические маркеры, диагностические критерии, клинические проявления, классификация, прогноз. // Тер. арх. 1998. — № 12. С.74−77.
- Руководство по внутренним болезням. Ревматические болезни, (под ред. Насоновой В. А., Бунчука Н. В. // «Медицина», Москва. 1997.
- Тареев Е.М. Коллагенозы.// Москва.- «Медицина». -1965.-С.74-.77.
- Хахалин. Л.Н., Соловьева Е. В. Герпесвирусные заболевания человека. // Клин, фармакол. и тер. 1998. — № 7 (1). — С. 72−76.
- Шварц Г. Я. Современные нестероидные противовоспалительные средства. М. Реафарм. 2002. — С. 17−19.
- Aceti A., Celestino D., Caferro М. et al. Basophil-bound and serum immunoglobulin E directed against Helicobacter pylori in patients with chronic gastritis. // Gastroenterol. 1991. — Vol.101 — P. 131−137.
- Alarcon-Segovia D. Vasculitis in systemic lupus erythematosus. // Lupus. -1997.-Vol.6.-P. 235−242.35. .Alarcon-Segovia D., Cardiel M. H., Reyes E. Antiphospholipid arterial vasculopathy. // J. Rheumatol. 1989. — Vol.16. — P.762−767.
- Andersen L.P., Blom J., Nielsen H. Survival and ultrastructural changes of Helicobacter pylori after phagocytosis by humam polymorphonuclear leukocytes and monocytes. // Apmis. 1993. — Vol.101. — P. 61−72.
- Andoh A., Fujiyama Y., Kitamura S. et al. Acute lupus peritonitis successfully treated with steroid pulse therapy. // J. Gastroenterol. 1997. -Vol.32 (5). — P.654−657.
- Archimandritis A., Markoulatos P., Tjivras M. et all. Herpes simplex virus types 1 and 2 and cytomegalovirus in peptic ulcer disease end non-ulcer dyspepsia. //Hepatogastroenterol. 1992. — Vol.39 (6). -P. 540−541.
- Asherson R.A., Cervera R. The antiphospholipid syndrome: A syndrome in evolution. // Ann. Rheum. Dis. 1992. — Vol.51. — P. 147−150.
- Bacharach J.M., Lie J.T. The prevalence of vascular occlusive disease associated with the antiphospholipid syndrome // Int. Angiol. 1992. -Vol.11.-P.51−56.
- Basso D., Gallo N., Zambon C.F., Baron M. Antigastric autoantibodies in Helicobacter pylori infection: role in gastric mucosal inflammation. //In.J. Clin.Lab. Res.-2000. Vol.30 (4). — P.173−178.
- Bayerdorffer E., Oertel H., Lehn N. et al. Topographic association between active gastritis and Campylobacter pylori colonisation. //J. Clin. Pathol. -1989. Vol.42. — P.834−839.
- Beekhuis J.W., Karrenbeld A. A patient with a cytomegalovirus infection and multiple stomach ulcers. // Ned.Tijdschr.Geneeskd. 1997. — Vol 141 (34). -P. 1657−1660.
- Belmont M.H., AbramsonS.B. Lie J.T. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium. // Arthritis Rheum. 1996 — Vol. -39. — P. 932.
- Bertele.V, Mussoni L., Pintucci G., del Rosso G., Romano G.: The inhibitory effect of aspirin on fibrinolysis is reversed by iloprost, a prostacyclin analog. // Thromb. Haemost. 1989. — Vol.61. — P. 286 — 288.
- Bickler S.W., Harrison M. W., Campbell J.R. Perforated peptic ulcer disease in children association of corticosteroid therapy. // J. Pediatr. Surg.-1993. -Vol.28 (6).-P.785−787.
- Bjornsson T. D., Schneider D. E., Berger Jr. H. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes inplasminogen activator levels. // J. Pharmacol. Exp. Ther. 1989. Vol. 250. -P. 159- 161.
- Brown C.H. Mesenteric arteritis with perforation of the jejunum in a patient with SLE. // Cleveland Clin.Quart. 1964. — Vol. 31. — P.169.
- Boston Collaborative Drug Surveillance Group: Regular aspirin intake and acute myocardial infarction. // Br. Med.J. 1974 — Vol.l. — P. 440.
- Burman P., Mardh S., Korberg L., Karlson F.A. Parietal cell antibodies in pernicious anemia inhibit H, К adenosine triphosphatase the proton pump of stomach. // Gastroenterol. — 1989. — Vol.96. — P.1434−1438.
- Cappell M.S., Mikhail N., Gujral N. Gastrointestinal hemorrhage and intestinal ischemia associated with anticardiolipin antibodies. // Dig.Dis.Sci. -1994. Vol.39 (6). -P.1359−1364.
- Chan F.K. Helicobacter pylori and nonsteroidal anti-inflammatori drags. // Gastroenterol. Clin. North. Am. -2001. Vol. 30 (4). — P.937−952.
- Cervera R., Khamashta M.A., Font J. et al. Morbidity and mortaliti in systemic lupus erythematosus during a 5-y period. A multicenter prospective study of 1000 patients. // Medicine. 1999. — Vol.78. — P.167−175.
- Chapman A.J., Farell H.E., Thomas J.A. et al. A murine cytomegalovirus -neutralising monoclonal antibody exhibits autoreactiviti and induces tissue damage in vivo. // Immunology. 1994. — Vol. 81. P.435−443.
- Chung A.B., Fas N., Successful acyclovir treatment of herpes simplex type-2 hepatitis in a patient with systemic lupus erythematosus: a case report and meta analysis. // Am.J.Med.Sci. -1999. Vol. 316 (6). P.404−407.
- Coghlan J., Gilligan D., Humphries H. et al. Campylobacter pylori and recurrence of duodenal ulcers- a 12-month follow-up study. // Lancet. -1987. Vol.2.-P.l 109−1 111.
- Colsky A.S., Jegasothy S.M., Leonardi C. et al. Diagnosis and treatment of cutaneous cytomegalovirus infection with a dramatic clinical presentation. // J.Am.Acad.Dermatol. 1998. — Vol. 38 (2). P. 349−351.
- Conn H.O., Poynard T. Adrenocorticosteroid administration and peptic ulcer: A critical analysis. // J. Chronic. Dis. 1985. — Vol.38. — P. 457
- Corey L., Spear P. Infection with herpes simplex viruses. // New Engl.J.Med. -1986. Vol.314. — P.686, 749.
- Costallat L.T.L, Coimbra A.M.V. Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. // Clin. Exp. Rheumatol. 1994. — Vol 12 — P.603−607.
- Crabtree J.E., Covacci A., Farmeri S.M. et al. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with Cag A positive phenotype. // J.Clin.Pathol. 1995. — Vol. 48. P. 41−45.
- Crabtree J.E., Perry S., Moran. et al. Neutrophil IL-8 secretion induced by Helicobacter pylori. // Am.J. Gastroenterol. 1994. — Vol.89. -P. 137.
- Craig P.M., Tenito M.C., Karnes W.E., Walsh J.H. Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. // Gut. -1992. -Vol.33.-P.1020−1023.
- Cullen D., Collins В., Christiansen K. et al. Long term risk of peptic ulcer disease in people with H. pylori infection- communiti based study. // Gastroenterol. 1993. — Vol. 104 (suppl.) — A.60.
- Current European concepts in the management of Helicobacter pylori infection. The Maastribt Consensus Report. // Gut. -2000. Vol.41 (1). — P.8−13.
- Daw M.A., Cotter L., Healy M. et al. Phospholipases and cytotoxic activiti of Helicobacter pylori. // Rev.Esp.Enf.Digest. 1990. — Vol.78 (1). — P.25.
- De Aispurua H.J., Ungar В., Toh B.H. Autoantibody to the gastrin receptor in pernicious anemia. // N. Engl. J.Med. 1985. — Vol.313. -P.479−483.
- De Schiyver-Kecskemeti K., Cleuse R.E. A previously unrecognised subgroup of «eosinophilic gastroenteritis». Assciation with connective tissue diseases. //Amer.J.Surg.Pathol. 1984. — Vol.8. — P.171−180.
- Drenkard C., Villa A.R., Reyes E., Abello M., Alarcon- Segovia D. Vasculitis in systemic lupus erythematosus. // Lupus. 1997. — Vol.6. P.235−242.
- Dubois E, Tuffanelli D. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. // J.Am. Med.Assoc. — 1964. Vol.190.-P.104−111.
- Dunn В., Campbell G.P., Perez-Perez G.I. et al. Purification and characterization of urease from Helicobacter pylon. //J. Biol. Chem.-1990. -Vol.265.-P.9464−9469.
- Dutch TLA Study Group: The Dutch TIA trial: protective effects of low-dose aspirin and atenolol in patients with transient ischaemic attacks or nondisabling stroke. // Stroke 1988. — Vol.19. — P.512−517.
- El-Zimaiti H.M., Genta R.M., Graham D.Y. Histological features do not define NSATO-induced gastritis. // Hum. Pathol. 1996. — Vol.27.- P. 13 481 354.
- Faller G., Keller K.M., Claeys D., Buderus S. et al. Prevalence and specificity of antigastric autoantibodies in adolescents infected with Helicobacter pylori. // J.Pediatr. 2002. — Vol.140 (1). — P.68−74.
- Fan X.G., Yakoob J., Fan X.J., Keeling P.W. Enhanced T-helper 2 lymphocyte responses: immune mechanism of Helicobacter pylori infection. // IrJ. Med. Sci. 1996. — Vol. 165. — P.37−39.
- Fan X.J., Chua A., O' Connell M.A. et al. Interferon-gamma and tumor necrosis factor production in patients with Helicobacter pylori infection. // Isr.J.Med. Sci. 1993. — Vol. 162 (10). — P.408−411.
- Fan X.J., Chua A., Shahi C.N. et al Gastric T-lymphocyte responses to Helicobacter pylori in patients with H. pylori colonisation. // Gut. 1994. -Vol. 35. -P.1379−1384.
- Farman J., Lerner M.E. et al. Cytomegalovirus gastritis protean radiologic features. // Gastrointest Radiol. 1999. — Vol. 17 (3). P.202−206.
- Font J., Lopes-Soto A., Cervera R. et al. The primari antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients. //Autoimmuniti 1991. — Vol.9. -P.69−75.
- Fontham E.T., Ruis В., Peres A. at al. Determinants of Helicobacter pylori infection and chronic gastritis. // Am. J Gastroenterol. -1995. Vol 90 (70). -P.1094−1101.
- Franceschi F., Sepulveda A.R., Gasbarrini A. et al. Crossreactivity betwen anti-Cag A antibodies and vascular antigens. European Helicobacter Stady Group. // Abstracts from Strasbourg Workshop. 20 011 — May.
- Friedberg M.A., Schwarts J.C., Feinman M.C. et al. Systemic herpes infection diagnosed by retinal biopsy. // Ophthalmic Surg. 1993. — Vol 24 (3). -P.203−205.
- Fries J.F. Non-steroidal anti-inflammatory drug safety: a view from ARAMIS databanc. // Curr. opinion Rheumatol. 1996. — № 8, suppl.l. — P.7−8.
- Fries J.F., Williams C.A., Bloch D.A., Michel B.A. Nonsteroidal antiinflammatory drug-associated gastropathy. Incidence and risk factor models. // Am.J. Med. 1991. — Vol.91. — P.213-
- Gabriel S. E., Jaakkimainen L., Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. // Ann. Int. Med. 1991 — Vol.115. -P.787.
- Genta R.M., Hamner H.W., Graham D.Y. Gastric lymphoid follicles in Helicobacter pylori infection: Frequency, distribution, and response to triple therapy. // Hum. Pathol. 1993. — Vol. 24 (6). — P.577−583.
- Graham D. Y, Smith J. L.: Aspirin and the stomach. // Ann. Intern. Med. -1986. Vol.104. — P. 390 — 398.
- Graham D., Lew G., Klein P. et al. Effect of treatment of Helicobacter pylori infection, on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. // Ann.Intern. Med. 1992. -Vol.116. — P.705−708.
- Grossmann, M. I., Matsumota, К. K., Lichter, R. J.: Fecal blood loss by oral and intravenous administration of various salicylates. // Gastroenterol. -1961 -Vol.40-P. 383−388.
- Gupta S., McCune W.J., Kaplan M.J. et al. Thrombosis and ischemia in patients with systemic lupus erythematosus treated with celecoxib: a series of two cases. // Arthritis.Rheum. -1999. 42 (Suppl.): S149 (abstract).
- Hallas, J., Jensen, К. В., Grodum, E., Damsbo, N., Gram. L. F.: Drug-related admissions to a department of medical gastroenterology. The role of self-medicated and prescribed drugs. // Scand. J. Gastroenterol. 1991. — Vol.26. P.174−175.
- Hats R.A., Meimarakis G., Bayerdorffer E. et al. Characterisation of lymphocitic infiltrates in Helicobacter pylori-associated gastritis. // Scand.J. Gastroenterol. 1996. — Vol 31. — P. 222−228.
- Hawkey C.J. Non-steroidal anti-inflammatory drug gastropathy: causes and treatment. // Scand. J. Gastroenterol. 1996. — Vol 222. — P. 12−17.
- Hawkey C.J., Somerville K.W., Marshall S.: Prophylaxis of aspirin induced gastric mucosal bleeding with ranitidine. //Alimentary Pharmacol. Ther. -1988.-Vol.2.-P.245−252.
- Hawthorne А. В., Mahida Y. R., Cole A. T, Hawkey C. J.: Aspirin-induced gastric mucosal damage prevention by enteric coating and relation to prostaglandin synthesis. // Br. J. Clin. Pharmacol. — 1991. — Vol.32. — P.77
- Hayashi Т., Lee S., Ogasawa H. at al. Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. // Lupus. 1998. — Vol. 7 (8).-P. 561−564.
- Hiraishi H., Konishi Т., Ota S., Shimada T. et al. Massive gastrointestinal hemorrhage in systemic lupus erythematosus: successful treatment with corticosteroid pulse therapy. // Am. J. Gastroenterol. 1998.- Vol.94 (11). -P.3349−3353.
- Hirsh, J., Levine, M.: Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures. // Brit. J. Clin. Practice. 1989 -Vol.65 (Suppl.). — P. 2−8.
- Howiler W., Coldberg H.I. Gastroesophageal involvement in Herpes simplex. // Gastroenterol. 1976. -Vol. 70 (5). — P 775−778.
- Hughes GRV. The antiphospholipid syndrome. // Lupus. -1996. -Vol.5. -P.345−346.
- Ikura Y., Matsuo Т., Ogami M. et al. Cytomegalovirus associated pancreatitis in a patient with systemic lupus erythematosus. // J.Rheumatol. 2000. -Vol.27 (11). -P.2715−2717.
- Isuji S., Kawano S., Sasayama Y. et al. Mucosal myeloperoxidase and IL-8 levels as predictor for peptic ulcer healing in human. // DDW. 1996.
- Ivey K. J., Paone D. В., Krause W. J.: Acute effect of systemic aspirin on gastric mucosa in man. // Dig. Dis.Sci. 1980. — Vol.25. — P.97−99.
- Kekki M., Varis K., Pehjanpelo H. et al. Course of antrum and body gastritis in pernicious anemia familis. Dig. Dis.Sci. — 1983. — Vol.28. -. P.698−704.
- Kalman D. R, Khan A., Romain P.L., Nompleggi D.J. Giant gastric ulceration associated with antiphospholipid antibody syndrome. // Am.J.Gastroenterol. -1996. Vol.91 (6). — P. 1244−1247.
- Karvonen A.L., Lehtola J. Gastric mucosae erosions, a clinical history and finding and possible role of herpes simplex. // Ann.Clin. Res. — 1983. -Vol. 15 (4). P.137−141.
- Kauffman G. Aspirin-induced gastric-mucosal injury lessons learned from animal models. // Gastroenterol. 1989. — Vol. 96. — P. 606.
- Kemker B.P. Ir., Docherty J.J., De Lucia A., Ruf W., Levis R.D. Herpes simplex virus: a possible etiologic agent in somegastroduodenal ulcer disease. // Am. Surg. 1992. — Vol.58 (12). — P. 775−778.
- Kitchingman G. K., Prichard P. J., Daneshmend Т. K. et al.: Enhanced gastric mucoal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine. // Br. J. Clin. Pharmacol. 1989. — Vol. 28. — P. 581−585.
- Konturek S.J., Brsosowski Т., Drosdowics D. et al. Role of leukotrienes and platelet- activating factor in acute gastric mucosal lesions in rat. // Eur. J.Pharmacol. 1989. — Vol.164 -. P. 285−292.
- Kranke В., Mayr-kanhauser S., Aberer W. Helicobacter pylori in acquired cold urticaria. // Contact. Dermatitis. 2001. Vol. 44 (1). -P. 57−58.
- Ku S.C., Yu C.J., Chang Y.L., Yang P.C. Disseminated cytomegalovirus disease in a a patient with systemic lupus erythematosus not undergoing immunosuppressivetherapy. // J. Formos Med.Assoc. 1999. -Vol 98 (12). — P. 855−858.
- Kudva Y.C., Peterson L.S., Holley K.E., Wright A.J., Hunder G.G. SLE nephropathy in a patient with HIV infection: case report and review of the literature. //J.Rheumatol. -1996. Vol.23 (10)-P.1811−1815.
- Lach- Trifilieff E., Marfurt J. Schwars S., Sadallah S., Schifferli J.A.Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erytematosus and HIV-infected patients. // J.Immunol. 1999. — Vol.162 (12). — P.7549−7554.
- Lai K.C., Lam S.K., Chu K.M., Wong B.C. et al. // Lansoprazole for the prevention of recurrences of ulcer complications from lonh-term low-dose aspirin use. // N. Engl. J. Med. -2002 Vol.27- 346 (26). — P.2033−2038.
- Lanza F. L., Royer G. L, Nelson R. S. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric coated aspirin on gastric and duodenal mucosa. // N. Engl.J. Med. 1980. — Vol. 303. — P. 136.
- Lee C.K., Ahn Ms., Lee E.Y., Shin J.H. et al. Acute abdominal pain in systemic lupus eiytematosus- focus on lupus enteritis (gastrointestinal vasculitis). //Ann.Rheum.Dis. 2002. -Vol.61 (6). — P.547−550.
- Leen-jan van Doom, Figueiredo C., Sanna R., Plaisier A. Clinical relevance of the Cag A, vac A and ice A status of Helicobacter pylori. // Gastroenterol. 1998. Vol 1. — P.58−66.
- Lie J.T. Vasculopathy in antiphospholipid syndrome: Thrombosis or vasculitis, or both? // J. Rheumatol. 1989. — Vol.16. — P.713−715.
- Lie J.T. Vasculopathy of antiphospholipid syndromes revisited: thrombosis is the culprit and vasculitis the consort. // Lupus. -1996. Vol.5 -P.368−371.
- Lockshin M. Lupus and antiphospholipid antibodi syndrome: either, neither, or both. // Am. J. Med.-1994. Vol. 96. — P. l, 2.
- Luckak B.K., Sansaricy C., Sayderman S.E., et al. Disseminated ulceration in allergic eosinophilic gastroenterocolitis. // Amer.J.Gastroenterol. 1982. -Vol.77.-P.248−252.
- Mai U.E.H., Peres-Peres G.I., Allen J.B. et al. Surfase proteins from Helicobacter pylori exibit chemotactic activiti for human leukocytes and are present in gastric mucosa. // J. Exp.Med. -1992. Vol.175. — P. 517−525.
- Mai U.E.H., Peres-Peres G.I., Blaser M.J., Smith P.D. Mechanism of H. pylori-induced inflammation in gastritis. // Rev.Esp. Enf.Digest. -1990- Vol. 78: P. 54.
- Malaty H., Paykov V., Bukova O. et al. Helicobacter pylori and socioeconomic factor in Russia. // Helicobacter. 1996. — Vol. 1(2). — P. 8287.
- Marshall B.J., Warren J.R. Unidentified curved bacilli in the stomach of the patients with gastritis and peptic ulceration. // Lancet. 1984. -Vol 1. — P. 1311−1315.
- McCarthy С., McDermont M., Hourihane D., О' Moranin С. Chemical gastritis induced by naproxen in the absence of Helicobacter pylori infection. // J. Clin. Pathol. 1995. — Vol. 48. — P.61−63.
- Messer J., Reitman D., Sacks H.S., et al. // Association of adrenocorticosteroid therapy and peptic- ulcer disease. // New. Engl. J. Med. 1983. — Vol.309. — P.21−24.
- Monreal M., BoixJ., Humbert P., Lafos E. et al. Gastroduodenal ulcer incidence in patients with venous thromboembolism. Gastrointest.Endosc. -1989. Vol.35 (5). — P.386−388.
- Moran A.P. Fhe role of lipopolysaharidi in Helicobacter pylori pathogenesis //. Alim. Pharmacol. 1996. -Vol 10. — P. 39−50.
- Morson B.C., Dawson J.M.P. Gastrointestinal Pathology. 2nd. -Oxford. — Blackwell. — 1979.
- Murray K.N., Parker A., Kadakia S.C. et all. Cytomegalovirus in upper gastrointestinal ulcers. // J. Clin. Gastroenterol. 1994. — Vol. 19 (3). -P 198−201.
- Nadorra R.L., Nakazato Y., Landing B.H. Pathologic features of gastrointestinal tract lesion in childhood-onset systemic lupus erythematosus: study of 26 patients, with review of the literature. // Pediatr. Pathol. 1987 — Vol. 7. — P.245−259.
- Neilsen H., Birkhols S., Andersen L.P., Moran A.P. Neutrophil activation by Helicobacter pylori lipopolysaccharide. // J.Infect.Dis. -1994.-Vol.170.-P.135−139.
- Nelson A.C., Crippin J.S.Gastritis secondary to herpes simplex virus. // Am. J. Gastroenterol. 1997. — Vol. 92 (11). — P. 2116−2117.
- Okada M., Fuchigami Т., Iida M., Omae Т. et al. Adrenocorticosteroid therapy and gastroduodenal lesions. // Gastrointest. Endosc. 1985. — Vol. 31 (3). — P. 188−190.
- Osier W. On the visceral complication of erythema exudativum multiforme. // Am.J.Med. Sci. 1895. — Vol.110. — P. 629−646.
- Ostensen M., Villiger P.M. Nonsteroidal antiinflammatori drugs in systemic lupus erythematosus. // Lupus. 2001. — Vol.10. — P.135−139.
- Pasceri V., Cammarota G., Patti G. et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. // Circulation 1998. — Vol. 97 (17). — P.1675−1679.
- Patra S., Samal S.C., Chacko A., Mathan V.I., Mathan M.M. Cytomegalovirus infection of the human gastrointestinal tract. // J.Gastroenterol.Hepatol. 1999. — Vol. 14 (10). — P. 973−976.
- Pecora P., Kaplan B. Corticosteroids and ulcers: is there an association? // Ann. Phannacother. 1996. — Vol.30. — P.870−872.
- Pellicano R., Massarello M.G., Morelloni S., Allegri M., Arena V., Ferrari M., Rissetto M., Ponsetto A. Acute myocardial infarction and Helicobacter pylori seropositiviti. // Int.Clin.Lab.Res. -1999. Vol. 29 (4). — P.141−144.
- Percival A.L., Nielsen R., Blom J. In vitro survival of Helicobacter pylori with human peripheral neutrophile granulocytes. // Rev. Esp. Enf. Digest. — 1990. Vol. 78.-P 62.
- Persoons M.C., Stals F.S., van dam Mieras M.C., BruggermanC.A. Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology. // J.Patol. -1998- Vol. 184 (1).-P. 103−109.
- Piette J.C., Wechsler В., et al. Exclusion criteria for primari antiphospholipid syndrome. //J. Rheumatol. 1993. -Vol.20. — P.1802−1803.
- Plotkin S. CMV: Pathogenesis and Prevention of Human Infection. // New York. 1984. — P.20−45.
- Posthuma E.F., Warmerdam P., Chandie Shaw M.P., Breedveld F.C. et al. // Gastric outlet obstruction as a presenting manifestation of systemic lupus erythematosus. // Gut. 1994. — Vol.35 (6). — P.841−843
- Poynard T. Critical study of gastroduodenal complications of corticotherapy. // Rev.Pract. 1990. — Vol. 40 (6). — P.553−555.
- Preston F. E., Whipps S., Jackson C. A., French A. J., Wyld P. J., Stoddard C. J.: Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. // N. Engl. J. Med. 1981. — Vol.304. — P. 76−79.
- Prichard P. J., Kitchingman G. K., Hawkey C. J.: Gastric mucosal bleeding: what dose of aspirin is safe? // Gut. -1987. Vol 28. -A 1401.
- Prichard P. J., Kitchingman G. K., Walt R. P., Daneshmend, Т. K., Hawkey, C. J Human gastric mucosal bleeding induced by low-dose aspirin, but not warfarin. // Br. Med. J. 1989. — Vol- 298. — P.493 — 496.
- Rainsford K. D.: Zeilulare Mechanismen der gastrointestinalen Schleimhautschadigung durch nichtsteroidale Antirheumatika. Nichtsteroidale Antirheumatika und Gastrointestinaltrakt. // Schattauer, Stuttgart New York -1987.-P.l-10.
- Rauws E., Tytgat G. Cure of duodenal ulcer associated with eradication of H.pylori. // Lancet. 1990. — Vol.335. — P.1233−1235.
- Ruis A.R., Borum M.L. Cytomegalovirus hemorragic gastritis. ATOS Patient Care SIDS. -2001. Vol.15 (1). -P.l-5.
- Schoen, R. T, Vender, R. J.: Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. // Am. J. Med. -1989. Vol 86. -P. 449.
- Shapeero L.G., Myers A., Oberkircher P.E., Miller W. T Acute reversible lupus vasculitis of the gastrointestinal tract. // Radiology. -1974. -Vol.112. -P.569−574.
- Singh G. Recent considerations in nonsteroidal anti-inflammatory drag gastropathy. // Am. J. Med. -1998. Vol.105 (IB). — P.31−38.
- Sipponen P., Seppala K., Aaiynen M. et al. Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis. I I Gut. 1989. — Vol. 30. -P. 922−929.
- Smith W. L., Marnett L. J., De Witt D. L.: Prostaglandin and thromboxane biosynthesis. //Pharmac. Ther. 1991. — Vol. 49. -P.153.
- Strauss S.E. Herpes simplex virus infection: Biology, treatment and prevention. // Ann.Intern.Med. 1985. — Vol.103. — P.404.
- Suerbaum S., Hur C., Josenhans C. et al. Pathogenesis and virulence factors of Helicobacter pylori. // Curr. Opin. Gastroenterol. 1999. — Vol.15. -Supl.l. -P.S11-S16.
- Sullivan T.J. The role of eosinophils in inflammatory reactions. In: Progress in Hematology, ed. by Brown E.B. // Grune and Stratton, New York. 1979. -P.65−82.
- Sultan S.M., Ioannou Y., Isenberg D.A. A review of gastrointestinal manifestations of systemic lupus erythematosus. // Rheumatol. -1999. -Vol.38. -P.917−932.
- Susuki M., Ochi Y., Hosokawa S. et.al. A multiple gastric ulcer case caused by cytomegalovirus infection. // Tokushima J.Exp. Med. -1996. Vol. 43 (3−4).-P. 173−176.
- Tamura K., Yamamura M., Nishigami T. et al. Effects of cytotoxic factors of Helicobacter pylori on superoxide generation in situ in the rabbit stomach. // Eur. J. Gastroenterol. Hepatol. 1994. — Vol.6-Suppl.l. -S.39−43.
- Tan E.M., Cohen A.S., Fries J.F.et.al. The 1982 revised criteria for the classification of systemic lupus erythematosus. // Arthr. Rheum. -1992. -Vol.25. -P.1271−1277.
- Tham K.T., Peek R.M.jr., Atherton J.C., Cover T.L., Peres-Peres G.I., Shyr Y., Blaser M.J. Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease. // Hum. Pathol. 2001. -Vol.32 (3).-P. 264−273.
- Vanegas F., Montalvo R.D. et all. Massive upper gastrointestinal hemorrahage due to cytomegalovirus infection in two patient with acquired immunodeficency syndrome. // South.Med. J. 2000. — Vol. 93 (2). — P.235−238.
- Vergara M., Herrero J., de Torres I., Armengol J.R., Saperas E., Malagelada J.R.Gastric ulcers as the only manifestation of infection by cytomegalovirus in immunocompetent patients. // Gastroenterol.Hepatol. 1998. — Vol. 21 (7). -P. 332−334.
- Vilaichone R.K., Mahachai V, Eim-ong S., Kullavanuaya P., Wisedopas N., Bhattarakosol P. Necrotising ileitis caused by cytomegalovirus in patient with systemic lupus eiythematosus: case report. // J. Med.Assoc. Thai. 2001. -Vol. 84. — P.469−73.
- Vorobjova Т., Faller G., Maaroos H.I., Sipponen P. et al. Significant increase in antigastric autoantibodies in a long-term follow-up study of H. pylori gastritis. // Virchows Arch.-2000. Vol. 437 (1). — P.37−45.
- Wallace D.J. Gastrointastinal and hepatic manifestations. In: Dubois' lupus erythemathosus. 5th edition. Editors: Wallace D. J, Hahn B.H. Los Angeles, CA. 1997. — P.835−844.
- Wallace D.J., Metzger A.L., Klinenberg J.R. NSAID usage patterns by rheumatologists in the treatment of SLE. // J. Rheumatol. 1989. — Vol.16. P.557−560.
- Walsh J., Peterson W. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. // N. Engl.J. Med. 1995. — Vol. 333 (15). -P.984−991.
- Watanabe Т., Goto H., Arisawa T. et al. Local immune response in Helicobacter pylori -infedted gastric mucosa: investigation of Hp-specific IgA in gastric juice. // Gut. -1997. 41 (Suppl): — A 62.
- Whincup P.H., Mendall M.A., Perry I.J., Strachan D.P., Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. // Heart. 1996. — Vol.75 (6). — P. 568−572.
- Whittle B. J. R.: Unwanted effects of aspirin and related agents on the gastrointestinal tract. Aspirin and Other Salicylates. // Chapman & Hall Medical. London. — 1992. — P.465−509.
- Wilson W.A., Gharavi A.E., Koike T. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. //Arthr. & Rheum. -1999. -Vol.42. P.1309−1311.
- Yoshida N., Granger D.N., Evans D.J. Jr. et al. Mechanism involved in Helicobacter pylori-induced inflammation. // Gastroenterol. 1993. -Vol. 105. — P.1431−1440.